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Bridging the translational divide: 
identical cognitive touchscreen 
testing in mice and humans 
carrying mutations in a disease-
relevant homologous gene
J. Nithianantharajah1,2,†, A. G. McKechanie3,4, T. J. Stewart4, M. Johnstone4, 
D. H. Blackwood4, D. St Clair5, S. G. N. Grant1,2,*, T. J. Bussey6,* & L. M. Saksida6, *
Development of effective therapies for brain disorders has been hampered by a lack of translational 
cognitive testing methods. We present the first example of using the identical touchscreen-
based cognitive test to assess mice and humans carrying disease-related genetic mutations. This 
new paradigm has significant implications for improving how we measure and model cognitive 
dysfunction in human disorders in animals, thus bridging the gap towards effective translation to the 
clinic.
There is a need for methods that address conserved mechanisms in rodents and humans, thus ena-
bling translation. The last decade has seen increasing calls to develop improved, standardised assays 
for assessing behavior in animals, to not only advance robustness of scientific practice between labora-
tories, but the fundamental goal of effective medical translation. This need has been further fuelled by 
recent pharmaceutical industry cut-backs on central nervous system drug development due to a lack 
of effective outcomes from clinical trials. Rodent models of disease – with their financial and ethical 
advantages compared to non-human primates, and the relative ease of genetic and other manipula-
tions – are an essential plank in this endeavor. However, one reason for the failures in clinical trials is 
likely the poor translational efficacy of the assays and measures employed to model clinical symptoms 
in rodents: pre-clinical testing of drugs for cognition is largely carried out using tests that have little in 
common with tests used in the clinical setting. A clear way forward in bridging the translational divide 
is the development of assays – ideally identical assays – that can be administered to both animals and 
humans, featuring objective and quantitative measures. Indeed, some progress to this end, mostly in 
non-human primate models, has already been made1–4. To this end, we present the first example of using 
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the identical touchscreen-based cognitive test to assess complex problem solving in mice and humans 
carrying disease-related genetic mutations in homologous genes.
Testing cognition in humans and rodent models in an identical manner has traditionally been dif-
ficult, however we previously highlighted the development of the rodent touchscreen operant platform 
which has made this a possibility5. The rodent touchscreen tests use the same well-controlled, accurate 
and automated touchscreen methodology that is increasingly used in human testing (e.g., Cambridge 
Neuropsychological Test Automated Battery, CANTAB), providing a unique translational tool6. A recent 
study, which is the only example that comes close to this kind of cognitive translation, involved a mouse 
model with a mutation in a member of the postsynaptic Discs large homolog – Membrane Associated 
Guanylate Kinase (Dlg-MAGUK) family of scaffold proteins assessed on rodent touchscreen tests com-
pared to human participants with copy number variations (CNVs) in the same gene assessed on 3 anal-
ogous – but not identical – CANTAB tests7.
While comparison of animals tested on rodent touchscreen tests to humans tested on human touch-
screen tests is an improved approach to measuring similar underlying cognitive components, the like-
lihood of tapping into the same components would be maximised by employing the same test in both 
species. Therefore, to demonstrate the full translational capacity of the touchscreen assays, we employed 
the identical touchscreen test to assess both mice lacking the Dlg2 gene (Dlg2−/−) and individuals with 
DLG2 CNV deletions on the rodent version of the object-location paired-associates task. This test 
requires learning and remembering which of three objects (flower, plane, spider) is associated with one 
of three locations on the touchscreen (left, centre, right respectively) (Fig.  1a)8, therefore learning the 
paired-association between the shape and the object’s location. Control wild-type (WT) mice show a pro-
gressive increase in performance across blocks of training trials on this task, indicating intact visuo-spatial 
learning and memory. In comparison, Dlg2−/− mice show a robust impairment in object-location paired 
associates learning, with performance consistently around 50% (chance level) across training (Fig. 1b). 
Similar to WT mice, human control participants showed progressive acquisition of object-location paired 
associates across training trials, with no differences in performance due to either gender or IQ (Fig. 1c, 
Supplementary Fig. 1). Interestingly, however, individuals with DLG2 CNV deletions tested on the same 
test failed to show this progressive acquisition and their performance was impaired compared to controls 
Figure 1. Mice and humans with mutations in Dlg2 tested on the identical rodent touchscreen object-
location paired associates task. (a) Rodent object-location paired associates learning test with 6 trials types 
(S+ , correct; S− , incorrect). (b,c) Performance across blocks of training trials for Dlg2–/– mice (b) and 
individuals with DLG2 CNV deletions (c). Mouse: significant differences in genotype, blocks of trials and 
genotype x block interaction (p < 0.005); post hoc analysis revealed Dlg2−/− mice were significantly impaired 
compared to WT mice across all 3 blocks of trials (p < 0.01). Human: controls show significant differences 
across blocks of trials (p < 0.001); post hoc analysis revealed improved performance from blocks 1 to 2 and 
3 (p < 0.005). In contrast, DLG2 participants were impaired and failed to show this progressive acquisition 
(p = 0.549). *p < 0.01.
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by the end of training, with performance still approximately at chance level (Fig. 1c, Supplementary Fig. 
1). These results strikingly recapitulate the impairment that we observe in Dlg2−/− mice.
Human mutations in DLG2 are rare but highly penetrant and have been reported in psychiatric dis-
orders including schizophrenia9–12 and more recently autism13, intellectual disability14 and bipolar dis-
order15. Moreover, cognitive ability in the general population has also been shown to be influenced by 
genetic variation in the postsynaptic signalling complexes formed by MAGUKs, highlighting the impor-
tance of genes within these complexes – including DLG2 – in regulating cognitive function16. This is 
evident within our data: of the 4 DLG2 CNV carriers, one individual is clinically unaffected but showed 
a similar pattern of performance as the other 3 participants with clinical diagnoses in contrast to con-
trols in this study and additionally, other CANTAB tests7. These findings highlight the need for future 
collaborative studies to increasingly identify individuals harbouring rare gene mutations and employ our 
approach of cognitive testing individuals based on their specific genetic architecture, both those with 
clinical diagnoses and unaffected individuals. In the current genomic era in which exome sequencing 
of large patient cohorts is routinely achievable, the genetic basis of neurological and neuropsychiatric 
disorders is rapidly being unravelled. Now more than ever, using animal models with targeted genetic 
manipulations combined with innovative behavioral methodology will be fundamental in effectively 
modelling disease-relevant cognitive dysfunction towards development of novel therapies. Our approach 
in developing identical assays that can be administered to both rodents and humans provides strong face 
validity which, although not guaranteeing construct or predictive validity without further work, is more 
likely to yield such ‘neurocognitive validity’ than the tasks that appear on the face of them to have little in 
common. This is not to say that more ecologically valid approaches are not desirable; indeed capitalising 
on species-specific behaviours can yield many advantages17. However for such approaches, just as with 
the touchscreen approach, the relevant criterion for utility in translation is neurocognitive validity. With 
the many advantages conferred by automated touchscreen testing6,8,18, the present study may represent 
the first example of what may become a new paradigm approach for effectively modelling cognitive 
dysfunction in animal models and effective translation to the clinic.
Methods
Animals. Homozygous knockout mice for Dlg2 (Dlg2−/−) and WT littermates were generated from 
heterozygous intercrosses19 and maintained on a C57BL/6J background. Male mice (n = 10–15 per 
group) were used for cognitive testing on the touchscreen tasks as outlined previously7. Male mice were 
employed due to logistical limitations in not being able to test both male and female mice within the same 
apparatus, thereby avoiding potential confounds associated with prior observations of erratic behaviour 
displayed by male mice in apparatus where females had previously been tested. Mice were maintained 
on a restricted diet at or above 85% of their free-feeding body weight during behavioral testing. Water 
was available ad libitum throughout the experiment. All experimental protocols were approved by UK 
Home Office project licences and conducted in accordance with the United Kingdom Animals (Scientific 
Procedures) Act (1986).
Cognitive testing of mice in the rodent touchscreen operant system. Testing was conducted 
in a touchscreen-based automated operant system as that described previously7 that consisted of an 
operant chamber (21.6 × 17.8 × 12.7 cm) made of clear Perspex walls and a stainless steel grid floor, 
housed within a sound- and light-attenuating box (40 × 34 × 42 cm) (Med Associates, St Albans, VT). 
A dispenser delivering reward pellets (14 mg, BioServ, Frenchtown NJ) into a magazine, a house light 
and a tone generator were located at one end of the chamber. At the opposite end of the chamber was a 
flat-screen monitor equipped with an infrared touchscreen (16 × 21.2 cm) (Craft Data Limited, Chesham, 
UK). The touchscreen was covered by a black Perspex ‘mask’ with windows positioned in front of the 
touchscreen allowing the presentation of stimuli to be spatially localized and prevented the mouse from 
accidentally triggering the touchscreen. Stimuli presented on the screen were controlled by custom soft-
ware (“MouseCat,” L.M. Saksida; Carola Romberg) and responses made via nose-pokes at the stimuli 
were detected by the touchscreen and recorded by the software.
Object-location paired-associates learning. Animals were pre-trained through several phases for 
instrumental operant conditioning as that previously described7. Once animals successfully completed 
the pre-training phases, mice were moved onto the task proper. In the object-location paired-associates 
learning test, mice were tested for the ability to associate between objects (shapes) and locations on the 
touchscreen20,21. There were three objects (flower, plane, and spider) and three correct spatial locations 
(left, centre, and right, respectively). For each trial, only 2 objects were presented; one object in its correct 
location (S+ ) and the other object in one of two incorrect locations (S− ). There were six possible trial 
types21, so that the flower was rewarded only when presented in the left location, the plane was rewarded 
only when presented in the middle location, and the spider was rewarded only when presented in the right 
location. A nose-poke to the correct S+ resulted in delivery of a reward and incorrect responses resulted 
in a 5 s time-out period, followed by correction trial whereby the trial was repeated until the mouse made 
a correct choice. Nose-pokes to response windows in which no stimulus was presented were ignored. 
Mice were given 36 trials per session per day for 50 sessions to solve this complex problem-solving 
task. Mice were run in parallel in 20 sets of chambers, and so the experiment lasted approximately 60 
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days. Training on this task, which taps into more complex cognition, requires more training than some 
standard methods of testing rodent cognition (e.g., novel object recognition, fear conditioning or water 
maze) but is mitigated by many advantages6,18. For trial block analysis, data from 45 sessions (3 blocks of 
15 sessions) was used. Group differences were analyzed using a mixed between-within subjects ANOVA 
with genotype as the between-subjects factor and block as the within-subjects factor. A paired samples 
t-test was used for post hoc analysis to assess significant between x within-subjects interaction effects. All 
values reported represent mean ± standard error of the mean.
Human controls and DLG2 CNV participants. Control participants (males n = 14; females 
n = 16, ages 23–63, NART (National Adult Reading Test) score ≤ 120) with no history of major mental 
illness were recruited through the Family and Population Genetic Study of Mental Health at the Royal 
Edinburgh Hospital. Four individuals with CNV deletions within DLG2 participated in the current study 
(see Table  1). As previously described7, initial discovery of 4 unrelated cases of DLG2 CNV carriers 
(includes Participants 1 and 3) was made in the International Schizophrenia Consortium Genome Wide 
Association Study (GWAS)11 from 1115 Scottish schizophrenia cases (0.36%). From 978 Scottish control 
individuals screened, none was found to have this CNV. Expanding the pedigree of one of the individuals 
(Participant 1) discovered in the GWAS led to finding 2 more individuals within the same family with 
DLG2 CNVs (2 daughters; 1 diagnosed with schizophrenia (Participant 2) and 1 not affected (Participant 
4)). The study was carried out in accordance with the approved guidelines of the Multi-Centre Research 
Ethics Committee for Scotland and all patients or their legal proxy gave written informed consent for 
the collection of DNA samples for use in genetic studies.
Human touchscreen testing using the rodent object-location paired associates learning 
test. The rodent touchscreen object-location paired associates learning test was adapted to be admin-
istered using a human touchscreen tablet. The test was run in a similar way to that described above for 
mice. For each trial, only 2 objects were presented; one object in its correct location and the other object 
in one of two incorrect locations. In order to make the testing method comparable to the rodent proto-
col, participants were given minimal instructions. Participants were instructed that objects would appear 
on the screen and they were required to make a response by touching an object and that the computer 
would inform them if their choice was correct or not. A correct response resulted in a ‘CORRECT’ mes-
sage being displayed on the screen and incorrect responses resulted in an ‘INCORRECT – PLEASE TRY 
AGAIN’ message, followed by a correction trial. Participants were required to complete 72 trials. For trial 
block analysis, 3 blocks of 24 trials was used. Group differences were analyzed using the Friedman test 
and a Wilcoxon signed-rank test to assess post hoc differences. Direct comparison of mouse to human 
performance was analysed using a mixed between-within subjects ANOVA with genotype (controls/WT, 
DLG2 CNV deletion/Dlg2−/−) and species (human, mouse) as the between-subjects factors and block 
of trials as the within-subjects factor. All values reported represent mean ± standard error of the mean.
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